The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external ...

In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

From diet soda to zero-sugar ice cream, artificial sweeteners have been touted as a guilt-free way to indulge our sweet tooth ...

Some thrillseekers climb 46 high peaks, but a Corinth teen has a different achievement in mind. Conley Baldwin has decided to snowboard 30,000 vertical feet on 20 different mountains in the name ...

A common artificial sweetener can trigger dangerous insulin spikes, warns a new study. The spikes led to blood vessel ...

Jabil and Midwest Interventional Systems are partnering to expand what the two CDMOs can do for minimally invasive device ...

Ladenburg analyst Jeffrey Cohen initiated coverage of Beta Bionics (BBNX) with a Buy rating and $31 price target The medical device company ...

An artificial pancreas combines a glucose monitor with an insulin pump. In this video, Griffin Rodgers, MD, director of diabetes, digestive and kidney disease at the National Institutes of Health, ...

Baird last night initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target The firm believes Beta’s iLet Bionic ...